Mandate

Vinge advises Hilding Anders on acquisition of Carpe Diem

August 19, 2013

Vinge is advising Hilding Anders International AB in connection with the acquisition of Carpe Diem Beds of Sweden AB. Hilding Anders is the leading bedding provider in Europe and Asia, has net sales of 851m€ and employs 7,600 people at 23 sites in 19 countries. The sales in Sweden are mainly focused to the brands Hilding, Ekens, Stjärnbädden and the Norwegian premium brand Jensen. Carpe Diem is a premium Swedish bedding brand with exports into 20 countries.

The Vinge team advising Hilding Anders includes partner Erik Gabrielson and associate Kristian Ford. Partner Ingela Malmborg provided employment law advice and associate Eva Blum provided intellectual property law advice.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026